CD8A and hepatocellular carcinoma: Furthermore, IGF2BP3 read WTAP-mediated m6A modifications on circCCAR1, promoting CD8+ T cell dysfunction and preventing the ubiquitin-mediated degradation of PD-1 in HCC [83].